3 News & Press Releases found

LivaNova PLC news

FDA Grants the Hemolung® De Novo Clearance

PITTSBURGH – (BUSINESS WIRE) – November 15, 2021 – ALung Technologies, Inc., the leading provider of low-flow extracorporeal carbon dioxide removal (ECCO2R) technologies for treating patients with acute respiratory failure, announced that the Food and Drug Administration (FDA) has granted the Company De

Nov. 15, 2021

FDA Grants ALung Emergency Use Authorization (EUA) to the ALung for the Treatment of COVID-19

PITTSBURGH – (BUSINESS WIRE) – April 24, 2020 – ALung Technologies, Inc., the leading provider of low-flow extracorporeal carbon dioxide removal (ECCO2R) technologies for treating patients with acute respiratory failure, announced that the Food and Drug

Apr. 23, 2020

ALung Announces Commercial Development of its Breakthrough Next Generation Artificial Lung

PITTSBURGH–(BUSINESS WIRE)– April 4, 2020 – ALung Technologies, Inc., the leading provider of low-flow extracorporeal carbon dioxide removal (ECCO2R) technologies for treating patients with acute respiratory failure, announced the recent initiat

Apr. 3, 2020